OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug gets extended safety check in chinese patients
Disease control CompletedThis study followed Chinese patients with a heart-thickening condition who had already taken the experimental drug aficamten in an earlier trial. Researchers monitored them for long-term safety and side effects while they continued taking the medication. The goal was to understan…
Matched conditions: OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Heart drug's long-term safety tracked in follow-up study
Disease control CompletedThis study monitored the long-term safety of mavacamten, a medication for hypertrophic cardiomyopathy (a condition where the heart muscle thickens). It included 314 adults who had already completed earlier trials testing this drug. Researchers tracked side effects and safety over…
Matched conditions: OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2, PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC